Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast

被引:48
|
作者
Ringberg, A [1 ]
Idvall, I
Fernö, M
Anderson, H
Anagnostaki, L
Boiesen, P
Bondesson, L
Holm, E
Johansson, S
Lindholm, K
Ljungberg, O
Östberg, G
机构
[1] Malmo Univ Hosp, Dept Plast & Reconstruct Surg, S-20502 Malmo, Sweden
[2] Malmo Univ Hosp, Dept Pathol & Cytol, S-20502 Malmo, Sweden
[3] Univ Lund Hosp, Dept Pathol & Cytol, S-22185 Lund, Sweden
[4] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden
[5] Univ Lund Hosp, Dept Canc Epidemiol, S-22185 Lund, Sweden
[6] Hosp Helsingborg, Dept Pathol & Cytol, Helsingborg, Sweden
[7] Hosp Karlskrona, Dept Pathol & Cytol, Karlskrona, Sweden
[8] Hosp Vaxjo, Dept Pathol & Cytol, Vaxjo, Sweden
[9] Hosp Kristianstad, Dept Pathol & Cytol, Kristianstad, Sweden
[10] Hosp Halmstad, Dept Pathol & Cytol, Halmstad, Sweden
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 2000年 / 26卷 / 05期
关键词
breast cancer; in situ; nuclear grade; margin; growth pattern; prognosis; treatment; DCIS;
D O I
10.1053/ejso.1999.0919
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Method and Results: A standardized histopathological protocol has been designed, in which different histological characteristics of ductal carcinoma in situ (DCIS) are reported. nuclear grade (ng), growth pattern acccording to Andersen et nl., necrosis, size of the lesion, resection margins and focality. Using this protocol a re-evaluation of a population-based consecutive series of 306 cases of DCIS has been done as well as a thorough clinical follow-up. After a median follow-up of 63 months, 13% have developed ipsilateral local recurrences, invasive and/or in situ. Ipsilateral local recurrence-free survival (IL-RFS) was significantly better for patients operated with mastectomy (ME) or breast conserving therapy (BCT) with radiotherapy (RT) than for patients operated with BCT without RT (5-year IL-RFS 96% vs 94% vs 79%, P<0.001). In the subgroup of BCT without RT there were significant differences in IL-RFS between histopathological subgroups: ng 1 + 2 (non-high grade) vs ng 3 thigh grade; P = 0.014), non-high-grade without comedo-type necrosis vs non-high-grade with comedo-type necrosis vs high-grade (the Van Nuys classification system; P=0.025). Growth pattern (not diffuse vs diffuse) and margins (free vs involved or not evaluated) showed a tendency (P=0.07 and 0.05, respectively) to be associated to IL-RFS. In contrast, no significant differences in IL-RFS were found in subgroups based on mode of detection, focality or size. Ninety-four per cent of the local recurrences after BCT appeared at the previous operation site. Conclusions: In the BCT without RT group, combinations of either nun-high grade and not a diffuse growth pattern or non-high grade and free margins identified groups (constituting approximately 30% of the patients) were at low risk of developing ipsilateral recurrences (6-10%), compared to a 31-37% recurrence risk in the remaining groups during the observed follow-up time. The beneficial effect of post-operative RT for these low-risk groups can be questioned, and should be studied further. (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:444 / 451
页数:8
相关论文
共 50 条
  • [1] Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics
    Ringberg, A
    Anagnostaki, L
    Anderson, H
    Idvall, I
    Fernö, M
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (12) : 1514 - 1522
  • [2] Risk of Ipsilateral Breast Events in Patients with Ductal Carcinoma In Situ after Local Excision
    Yi, M.
    Kuerer, H. M.
    Lucci, A.
    Meric-Bernstam, F.
    Babiera, G. V.
    Thomas, C. L.
    Ross, M. I.
    Hunt, K. K.
    CANCER RESEARCH, 2010, 70
  • [3] Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast
    Silverstein, MJ
    Lagios, MD
    Martino, S
    Lewinsky, BS
    Craig, PH
    Beron, PJ
    Gamagami, P
    Waisman, JR
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1367 - 1373
  • [4] Predicting local recurrence in patients treated for ductal carcinoma in situ of the breast (DCIS)
    Martinez-Perez, Carlos
    Turnbull, Arran K.
    Ekatah, Gregory E.
    Arthur, Laura M.
    Fernando, Anu
    Sims, Andrew H.
    Thomas, Jeremy S.
    Dixon, J. Michael
    CANCER RESEARCH, 2018, 78 (04)
  • [5] Predicting factors of local recurrence in ductal carcinoma in situ of the breast
    Pumarola Brussosa, C.
    Castillo, H.
    Mula, C.
    Cebrecos, I.
    Caparros, X.
    Oses, G.
    Torras, I.
    Mension, E.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S96 - S96
  • [6] Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery for Ductal Carcinoma in Situ
    Fujita, Tetsuji
    ANNALS OF SURGERY, 2011, 253 (06) : 1233 - 1233
  • [7] Concurrent Lobular Neoplasia Increases the Risk of Ipsilateral Breast Cancer Recurrence in Patients With Ductal Carcinoma in Situ Treated With Breast-conserving Therapy
    Rudloff, Udo
    Brogi, Edi
    Brockway, Julia P.
    Goldberg, Jessica I.
    Cranor, Milicent
    Wynveen, Christine A.
    Nehhozina, Tatjana
    Reiner, Anne S.
    Patil, Sujata
    Van Zee, Kimberly J.
    CANCER, 2009, 115 (06) : 1203 - 1214
  • [8] A predictive model for local recurrence in patients treated for ductal carcinoma in situ of the breast (DCIS)
    Martinez-Perez, C.
    Turnbull, A. K.
    Fernando, A.
    Ekatah, G. E.
    Arthur, L. M.
    Cartlidge, C. W.
    Johns, N.
    Sims, A. H.
    Thomas, J. S.
    Dixon, J. M.
    CANCER RESEARCH, 2019, 79 (04)
  • [9] Impact of Microinvasion as a Predictor of Local Recurrence in Ductal Carcinoma In Situ Treated With Breast Conserving Therapy
    Lalani, N.
    Paszat, L.
    Sutradhar, R.
    Gu, S.
    Fong, C.
    Nofech-Mozes, S.
    Hanna, W.
    Tuck, A.
    Youngson, B.
    Miller, N.
    Done, S. J.
    Chang, M. C.
    Sengupta, S.
    Elavathil, L.
    Jani, P.
    Bonin, M.
    Rakovitch, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E27 - E27
  • [10] Local recurrence after breast conserving surgery for ductal carcinoma in situ
    Horvat, A. Gojkovic
    Gugic, J.
    Ratosa, I.
    Majdic, E.
    Marinko, T.
    Kosir, S. M. Paulin
    Jugovec, V.
    Korosec, P.
    Demsar, A.
    Kuhar, C. Grasic
    BREAST, 2015, 24 : S130 - S130